Related Experiment Video
Updated: May 2, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
3.7K
Advances in interventional cardiology: MitraClip.
Said Alsidawi1, Mohamed Effat, Tarek Helmy
1Division of Cardiovascular Health and Disease, College of Medicine, University of Cincinnati, 231 Albert Sabine Way, Cincinnati, OH, 45267, USA, alsidasd@ucmail.uc.edu.
Journal of Thrombosis and Thrombolysis
|March 5, 2014
Summary
MitraClip offers a safe and effective percutaneous treatment for severe mitral regurgitation in high-risk patients. This innovative device provides an alternative for those unsuitable for traditional surgery, improving outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Severe mitral regurgitation poses significant health risks, often leaving patients with comorbidities ineligible for conventional surgery.
- The MitraClip device presents a novel, less invasive treatment option for mitral valve regurgitation.
- Percutaneous edge-to-edge repair offers a new therapeutic avenue for high-risk surgical patients.
Purpose of the Study:
- To review the expanding clinical role of the MitraClip device.
- To discuss pivotal clinical trials evaluating MitraClip safety and efficacy.
- To outline potential complications associated with the MitraClip procedure.
Main Methods:
- Review of major clinical trials and ongoing studies on MitraClip.
- Discussion of the percutaneous edge-to-edge coaptation technique.
- Analysis of patient selection criteria for high-risk individuals.
Main Results:
- Clinical trials confirm the safety and efficacy of MitraClip for selected patients.
- The device provides a viable alternative for patients previously deemed non-surgical candidates.
- Understanding potential complications is crucial for successful patient management.
Conclusions:
- MitraClip is a growing therapeutic option for severe mitral regurgitation in high-risk patients.
- Evidence supports its use, with ongoing research further defining its role.
- Careful patient selection and awareness of potential complications are essential.
More Related Videos
Related Concept Videos
01:25Mitral Regurgitation III: Medical Management
686
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
01:26Mitral Stenosis III: Medical Management
535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
01:22Mitral Valve Prolapse II: Assessment and Management
1.4K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
01:29Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
01:27Peripheral Artery Disease III: Interprofessional Care
655
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
01:22Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K